GeoVax Labs Inc GOVX

Healthcare Biotechnology

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using proprietary platforms. Its product pipeline includes ongoing human clinical trials for a Covid-19 vaccine and a gene-directed therapy against advanced head and neck cancers. Its additional research and development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan and Marburg), Zika virus and malaria, as well as immunotherapies for multiple solid tumors. The Company’s portfolio of wholly owned, co-owned, and in-licensed intellectual property, stands at over 155 granted or pending patent applications spread over 24 patent families. Its product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02 and others. Its lead infectious disease candidate is GEO-CM04S1, a COVID-19 vaccine targeting high-risk immunocompromised patient populations.

NDAQ:GOVX - Post by User

GeoVax Labs Inc

<< Previous

Bullboard Posts

Next >>

(69)
•••

Post by Iseneschalon Jul 01, 2024 11:46am

47 Views

Post# 36113318

GOVX.....Ya pays yo money & yo takes yo chances

Might just be a P.O set up.....$3.60

Read this Effective P.O .....Jun 18

https://www.sec.gov/ix?doc=/Archives/edgar/data/832489/000143774924019645/govx20240531_s1.htm

<< Previous

Bullboard Posts

Next >>

How do I gift stock?